UNSPSC 51283960: Ditolamide

This classification denotes a sulfonamide anti-infective agent with the molecular formula C13H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AL8499KM94, chemically known as 4-methyl-n,n-dipropyl-benzenesulfonamide but more generally known as ditolamide, which bears US NIH Compound Identifier 208847. European Medicines Agency schedules Ditolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06335MIG. The term DITOLAMIDE is an International Non-Proprietary Name.

DITOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(N(CCC)CCC)C1CCC(CC1)C.

UNSPSC 51283960 Ditolamide, a Commodity code, encompasses pharmaceutical products and medical supplies that state and local public health agencies and counties procure through competitive bidding and cooperative purchasing vehicles. The code name does not reflect the actual breadth of recent state and local procurement activity — the most recent opportunities tagged to this code involve naloxone, drug deactivation systems, and antibiotic tablets rather than ditolamide itself. State and local issuing bodies include county health departments and state public health agencies, which source these products through piggyback contracts with established pharmaceutical consortiums or directly via invitation-for-bid processes to support community health, emergency preparedness, and disease prevention initiatives.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 multi-year piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) under IFB 26482DPHPREPDB53392. Seminole County, Florida issued an IFB (60459723LAS) posted June 30, 2026, with a July 26, 2023 response deadline (note: the due date appears to be a data anomaly), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; that procurement included FEMA funding and standard federal compliance requirements.